By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
RITALIN LA Drug Profile
Email this page to a colleague
Which patents cover Ritalin La, and what generic alternatives are available?
Ritalin La is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in RITALIN LA is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ritalin La
A generic version of RITALIN LA was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
Summary for RITALIN LA
See drug prices for RITALIN LA
Recent Clinical Trials for RITALIN LA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Florida | Phase 4 |
| State of Florida Consortium for Medical Marijuana Clinical Outcomes Research | Phase 4 |
| Wingate Institute | Phase 4 |
Pharmacology for RITALIN LA
| Drug Class | Central Nervous System Stimulant |
| Physiological Effect | Central Nervous System Stimulation |
ATC Classes for RITALIN LA
Paragraph IV (Patent) Challenges for RITALIN LA
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| RITALIN LA | CAPSULE, EXTENDED RELEASE;ORAL | methylphenidate hydrochloride | 021284 | 2007-05-21 |
| RITALIN LA | CAPSULE, EXTENDED RELEASE;ORAL | methylphenidate hydrochloride | 021284 | 2006-08-21 |
US Patents and Regulatory Information for RITALIN LA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-004 | Apr 10, 2004 | AB1 | RX | Yes | No | Try Before You Buy | Try Before You Buy | Try Before You Buy | |||
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-003 | Jun 5, 2002 | AB1 | RX | Yes | No | Try Before You Buy | Try Before You Buy | Try Before You Buy | |||
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-001 | Jun 5, 2002 | AB1 | RX | Yes | No | Try Before You Buy | Try Before You Buy | Try Before You Buy | |||
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-002 | Jun 5, 2002 | AB1 | RX | Yes | No | Try Before You Buy | Try Before You Buy | Try Before You Buy | |||
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-005 | Oct 27, 2014 | DISCN | Yes | No | Try Before You Buy | Try Before You Buy | Try Before You Buy | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RITALIN LA
International Patents for RITALIN LA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 1335000 | Try Before You Buy |
| South Korea | 20080024206 | Try Before You Buy |
| Norway | 20090158 | Try Before You Buy |
| Israel | 188093 | Try Before You Buy |
| Israel | 196065 | Try Before You Buy |
| Japan | 2009541360 | Try Before You Buy |
| Canada | 2697189 | Try Before You Buy |
| >Country | >Patent Number | >Estimated Expiration |
